Latest Breaking News On - University hospital in mainz - Page 1 : comparemela.com

The randomized, observer blind, placebo-controlled clinical Phase 3 study will include more than 2,500 subjects, 18 years of age and older, who will be randomized into this study out of the non-interventional trial. It complements the recent initiation of CureVacs global pivotal Phase 2b/3 trial, HERALD, for CVnCoV in more than 35,000 participants. The Phase 3 study builds on a non-interventional study on COVID-19 at the University Hospital Mainz involving 3,600 hospital employees, including medicine and dentistry students in their 5 th semester or higher. The study has been ongoing for several months and investigates the distribution (epidemiology) of COVID-19 in a collective of employees of a University Hospital. It focuses on the rate at which SARS-CoV-2-specific antibodies arise and can be detected in hospital employees as well as the frequency of virologically confirmed COVID-19 cases in this cohort of hospital employees.

United statesSarah fakihLidia oostvogelsUniversity hospitalExchange commissionUniversity medical center mainzUniversity hospital mainzUniversity hospital in mainzInfectious diseasesNew york nasdaqVice presidentVice president investorஒன்றுபட்டது மாநிலங்களில்சாரா ஃபேகிபல்கலைக்கழகம் மருத்துவமனைபரிமாற்றம் தரகு